Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
52.62
-0.16 (-0.30%)
Apr 7, 2026, 3:31 PM EDT - Market open
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $6.07 billion as of April 7, 2026. Its market cap has increased by 2,115.52% in one year.
Market Cap
6.07B
Enterprise Value
5.05B
1-Year Change
2,115.52%
Ranking
Category
Stock Price
$52.62
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $6.07B, an increase of 4,128.84%. That is a compound annual growth rate of 106.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 6.09B | 38.63% |
| Dec 31, 2025 | 4.39B | 833.82% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcellx | 6.74B |
| Protagonist Therapeutics | 6.52B |
| Apogee Therapeutics | 6.21B |
| Centessa Pharmaceuticals | 6.15B |
| Rhythm Pharmaceuticals | 6.01B |
| Mirum Pharmaceuticals | 5.78B |
| PTC Therapeutics | 5.76B |
| Scholar Rock Holding | 5.75B |